Yotsuya Naika

Shibuya-Ku, Tokyo 160-0017

1 studies enrolling now · 1 studies all time

What they study most

SARS-CoV-2

Studies at this site

• A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease — Starting soon